GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies

Journal of Neurology

Volumn 260, Issue 12, 2013, Pages 3086-3092

  Hosoi, Yasushi ^a   Suzuki Sakao, Makiko ^a   Terada, Tatsuhiro ^a   Konishi, Takashi ^a   Ouchi, Yasuomi ^a   Miyajima, Hiroaki ^a   Kono, Satoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ataxia; Flumazenil; Fluorodeoxyglucose; Glutamic acid decarboxylase; PET

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CLONAZEPAM; DIAZEPAM; FLUMAZENIL; FLUMAZENIL C 11; FLUORODEOXYGLUCOSE F 18; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN;

ADULT; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CEREBELLUM; CEREBELLUM ATROPHY; FEMALE; GABAERGIC TRANSMISSION; GLUCOSE METABOLISM; HUMAN; IN VIVO STUDY; MALE; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPSOCLONUS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STIFF MAN SYNDROME;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; BRAIN; CEREBELLAR ATAXIA; FEMALE; FLUMAZENIL; FLUORODEOXYGLUCOSE F18; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, GABA-A;

EID: 84890733981     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7092-y     Document Type: Article

References (30)

1. Abele M, Weller M, Mescheriakov S, Burk K, Dichgans J, Klockgether T (1999) Cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Neurology 52:857-859
2. Antonini G, Nemni R, Giubilei F, Gragnani F, Ceschin V, Morino S, Bucci E, Accornero N (2003) Autoantibodies to glutamic acid decarboxylase in downbeat nystagmus. J Neurol Neurosurg Psychiatry 74:998-999
3. Atack JR, Smith AJ, Emms F, McKernan RM (1999) Regional differences in the inhibition of mouse in vivo [3H] Ro 15-1788 binding reflect selectivity for alpha 1 versus alpha 2 and alpha 3 subunit-containing GABAA receptors. Neuropsychopharmacology 20:255-262
4. Bhandari HS (2012) Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies. BMJ Case Rep
5. Dinkel K, Meinck HM, Jury KM, Karges W, Richter W (1998) Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 44:194-201
6. Galldiks N, Thiel A, Haense C, Fink GR, Hilker R (2008) 11C-flumazenil positron emission tomography demonstrates reduction of both global and local cerebral benzodiazepine receptor binding in a patient with stiff person syndrome. J Neurol 255:1361-1364
7. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P, Graus F (2001) Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58:225-230
8. Howard FM Jr (1963) A new and effective drug in the treatment of the stiff-man syndrome: preliminary report. Proc Staff Meet Mayo Clin 38:203-212
9. Ishida K, Mitoma H, Song SY, Uchihara T, Inaba A, Eguchi S, Kobayashi T, Mizusawa H (1999) Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 46:263-267
10. Ishida K, Mitoma H, Wada Y, Oka T, Shibahara J, Saito Y, Murayama S, Mizusawa H (2007) Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia. J Neurol Neurosurg Psychiatry 78:190-192
11. Kono S, Miyajima H, Sugimoto M, Suzuki Y, Takahashi Y, Hishida A (2001) Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer. Intern Med 40:968-971
12. Markakis I, Alexiou E, Xifaras M, Gekas G, Rombos A (2008) Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase. Clin Neurol Neurosurg 110:619-621
13. Mata S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, Bisulli F, Paganini M, Mazzi G, Sorbi S, Tinuper P (2008) Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol 199:155-159
14. Meyer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE (1995) Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Arch Neurol 52:314-317
15. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238-1248
16. Mitoma H, Song SY, Ishida K, Yamakuni T, Kobayashi T, Mizusawa H (2000) Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci 175:40-44
17. Nemni R, Braghi S, Natali-Sora MG, Lampasona V, Bonifacio E, Comi G, Canal N (1994) Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol 36:665-667
18. Ouchi Y, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Sakamoto M (2002) Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study. J Cereb Blood Flow Metab 22:746-752
19. Peltola J, Kulmala P, Isojarvi J, Saiz A, Latvala K, Palmio J, Savola K, Knip M, Keranen T, Graus F (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55:46-50
20. Perani D, Garibotto V, Moresco RM, Ortelli P, Corbo M, Fazio F, Folli F (2007) PET evidence of central GABAergic changes in stiff-person syndrome. Mov Disord 22:1030-1033
21. Piccolo G, Tavazzi E, Cavallaro T, Romani A, Scelsi R, Martino G (2010) Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies. J Neurol Sci 290:148-149
22. Raju R, Rakocevic G, Chen Z, Hoehn G, Semino-Mora C, Shi W, Olsen R, Dalakas MC (2006) Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain 129:3270-3276
23. Rakocevic G, Raju R, Semino-Mora C, Dalakas MC (2006) Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology 67:1068-1070
24. Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, Graus F (1997) Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 49:1026-1030
25. Saiz A, Minguez A, Graus F, Marin C, Tolosa E, Cruz-Sanchez F (1999) Stiff-man syndrome with vacuolar degeneration of anterior horn motor neurons. J Neurol 246:858-860
26. Silbert PL, Matsumoto JY, McManis PG, Stolp-Smith KA, Elliott BA, McEvoy KM (1995) Intrathecal baclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial. Neurology 45:1893-1897
27. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, Vicari AM (1988) Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 318:1012-1020
28. Takenoshita H, Shizuka-Ikeda M, Mitoma H, Song S, Harigaya Y, Igeta Y, Yaguchi M, Ishida K, Shoji M, Tanaka M, Mizusawa H, Okamoto K (2001) Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry 70:386-389
29. Tilikete C, Vighetto A, Trouillas P, Honnorat J (2005) Anti-GAD antibodies and periodic alternating nystagmus. Arch Neurol 62:1300-1303
30. Witherick J, Highley JR, Hadjivassiliou M (2011) Pathological findings in a case of stiff person syndrome with anti-GAD antibodies. Mov Disord 26:2138-2139